Alan Jerusalmi, PhD is a seasoned scientific expert with 16 years working in Pharma industry and for leading technology platform companies. Alan has held technical and scientific leadership positions at Vertex Pharma, Roche, Definiens, WuXi Nextcode and RSIP Vision. He led the transformation of the Definiens Professional Services from a software licensing platform over to a leading clinical biomarker development services business.
Alan received his PhD from Trinity College Dublin and did his Postdoc at Harvard Beth Israel Deaconess Medical Center.
